Daniel Sherbenou, MD, PHD
13 years treating Multiple Myeloma | 200 Multiple Myeloma patients treated annually
As an undergraduate at the University of Colorado, I started my scientific career focused on basic science research of cancer. In the laboratory of Dr. Min Han, I studied the Ras cell signaling pathway using the C. elegans model organism. In an oncology fellowship at University of California at San Francisco, I focused on the study of antibody-based therapeutics under the mentorship of Dr. Bin Liu. Antibody-drug conjugates (ADCs) are another rapidly growing approach to cancer treatment. With Dr. Liu, I conducted preclinical analyses of a novel ADC for multiple myeloma, that I hope will soon lead to a new clinical treatment option. Now a faculty member at UC Denver in the Hematology division, I oversee a translational research laboratory focused on novel therapy development and optimization for multiple myeloma and will care for patients with myeloma and related plasma cell disorders in Colorado and adjoining areas.
University Of Colorado Cancer Center: 1665 Aurora Ct 3rd floor, Aurora, CO 80045, USA